BioSig Technologies

BioSig Technologies is dedicated to developing new ways to assist patients and doctors, with its first product being the PURE EP™ system, which is designed for the vast and growing electrophysiology market. Starting with the PURE EP™ system, the company is committed to developing and providing advanced medical processing solutions that will unlock the future of bioelectronic medicine—a rapidly evolving healthcare field that explores how targeted electrical signals can harness the body's natural mechanisms to diagnose and treat various diseases. This field represents not only a small category of medical devices but also an entire approach to detecting and treating diseases, using electrical pulses and the body’s own mechanisms as complementary or alternative means to drugs and medical procedures. The applications of bioelectronic medicine aim to provide therapeutic breakthroughs for many currently highly unmet medical needs. Researchers and innovators are exploring the use of this field across various disease areas and disciplines, including neurology, autoimmune diseases, diabetes, arthritis, hypertension, pain control, cancer, and more. This wide range of applications sets bioelectronic medicine apart and highlights its immense potential.